DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS

Clinical trials for DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS explained in plain language.

Never miss a new study

Get alerted when new DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS trials appear

Sign up with your email to follow new studies for DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 1 Terminated 1

Shorter TB course could be Game-Changer for HIV patients

Disease control Not yet recruiting

This study tests whether a shorter, 5-month combination of TB drugs works as well as the standard 6-month treatment for people with both HIV and drug-susceptible tuberculosis. It involves 148 participants with very weak immune systems (CD4 count under 100). The goal is to see if …

Matched conditions: DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS

Phase: NA • Sponsor: Shanghai Public Health Clinical Center • Aim: Disease control

Last updated Jun 27, 2026 12:38 UTC

DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS

Get alerted when new DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS trials appear

Shorter TB course could be Game-Changer for HIV patients